Huvepharma Returns the only FDA-Approved Triple-Sulfa Medication to US Market

reading time
Product | 26.10.2022
Peachtree City, GA, USA
25th October 2022

Huvepharma®, Inc. is re-launching PoultrySulfa® (sulfamerazine, sulfamethazine and sulfaquinoxaline), the only FDA-approved triple-sulfa veterinary product available to the animal health market in the US. PoultrySulfa® is a water-soluble antibiotic powder that can be used as an aid in the control of coccidiosis and acute fowl cholera in chickens and turkeys when caused by pathogens susceptible to sulfamerazine, sulfamethazine and sulfaquinoxaline.

"PoultrySulfa® gives the US Poultry Industry a safe and dependable FDA approved tool for managing outbreaks of two very costly diseases," says Dr. Steven Clark, veterinary services manager for Huvepharma®. Containing a unique combination of three active ingredients, PoultrySulfa® is potent, while providing a wider margin of safety compared to traditional single-sulfa products. In addition to its therapeutic properties, PoultrySulfa®'s water-soluble presentation allows for efficient delivery via the animals' drinking water. Simple and accurate dosing has also been taken into consideration; PoultrySulfa® comes in pre-measured, individually sealed packets. 

"Relaunching PoultrySulfa® further demonstrates Huvepharma®'s commitment to the chicken and turkey industry," says Dustin Toliver, Product Manager and National Account Manager for Huvepharma®. "We are dedicated to providing the needed management tools and resources to our poultry producing customers."

 

Important safety information

PoultrySulfa® (sulfamerazine, sulfamethazine and sulfaquinoxaline): Not for human use. Keep out of the reach of children. For oral use, in chickens and turkeys only. Do not treat chickens or turkeys within 14 days of slaughter. Do not medicate chickens or turkeys producing eggs for human consumption. Federal law prohibits the extra label use of this product in lactating dairy cattle. May cause toxic reactions unless drug is evenly mixed in water at dosages indicated and used according to label directions. To report adverse effects, access medical information, or obtain additional product information, call 1-877-994-4883. 

global presence

Local support from a global company

Huvepharma® has a distribution network which covers more than 90 countries in 6 continents. Find your nearest Huvepharma® representative today.
Find your local contact
about us

Huvepharma®

Huvepharma® is a fast-growing, global pharmaceutical company with a focus on developing, manufacturing and marketing human and animal health and nutrition products.
more about us

Change country

The Huvepharma® distribution network covers 90 countries in 6 continents. Please select a country from the list below to see the products and services available in that region.

To view all products and services, select Global from the dropdown menu or click .

Africa

Asia

Europe

North America

Oceania

South America

Change language

Huvepharma has a remarkable distribution network which covers 90 countries in 6 continents. To offer you the best services, we ask you to select your country.

Europe

top
Your browser is out of date!

Update your browser to view this website correctly. Update my browser now